Evidence map›Paper›PMID 33460469›Full record

ReviewClinical and experimental immunology2021

Keratinocytes: innate immune cells in atopic dermatitis.

P Chieosilapatham, C Kiatsurayanon, Y Umehara, J V Trujillo-Paez, G Peng, H Yue, L T H Nguyen, F Niyonsaba

Open access · bronzeAbstract readReview
In one paragraph

Review in Clinical and experimental immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 124 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
124citing papers in PubMed, 1 pooled it
23.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

124 citing papers in PubMed, 1 synthesis or guideline pooled it, 182 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Epidermal retinoid starvation driven by AKR1B10 orchestrates barrier disruption and hyperinflammation in atopic dermatitis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  9. Review
  10. TRPV4 mediates low-humidity responses in epidermal keratinocytes.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Review
  12. Review
  13. Epithelial-Dermal Immune Memory: TrackingInternational journal of molecular sciences · 2026
    Review
  14. Keratinocytes: A key player in skin immunity and their emerging roles in secondary lymphedema.JID innovations : skin science from molecules to population health · 2026
    Review
  15. Review
  16. Article
  17. Molecular maps of diseases from omics data and network embeddings.NPJ systems biology and applications · 2026
    Article
  18. SkinApplied and environmental microbiology · 2026
    Article
  19. Article
  20. Anti-Inflammatory Activities of Baobab Fruit Extracts in TNF-Pharmaceuticals (Basel, Switzerland) · 2026
    Article

64 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

P ChieosilapathamDivision of Immunology, Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
C KiatsurayanonInstitute of Dermatology, Department of Medical Services, Ministry of Public Health, Bangkok, Thailand.
Y UmeharaAtopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.
J V Trujillo-PaezAtopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.
G PengAtopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.
H YueAtopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.
L T H NguyenAtopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.
F NiyonsabaAtopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.ORCID 0000-0002-0588-8315
Juntendo University · JPChiang Mai University · THMinistry of Public Health · TH

Funding

Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan 26461703
6 · The paper itself

Abstract

The skin is a unique immune organ that constitutes a complex network of physical, chemical and microbiological barriers against external insults. Keratinocytes are the most abundant cell type in the epidermis. These cells form the physical skin barrier and represent the first line of the host defense system by sensing pathogens via innate immune receptors, initiating anti-microbial responses and producing various cytokines, chemokines and anti-microbial peptides, which are important events in immunity. A damaged epidermal barrier in atopic dermatitis allows the penetration of potential allergens and pathogens to activate keratinocytes. Among the dysregulation of immune responses in atopic dermatitis, activated keratinocytes play a role in several biological processes that contribute to the pathogenesis of atopic dermatitis. In this review, we summarize the current understanding of the innate immune functions of keratinocytes in the pathogenesis of atopic dermatitis, with a special emphasis on skin-derived anti-microbial peptides and atopic dermatitis-related cytokines and chemokines in keratinocytes. An improved understanding of the innate immunity mediated by keratinocytes can provide helpful insight into the pathophysiological processes of atopic dermatitis and support new therapeutic efforts.

Indexed as

AllergensChemokinesCytokinesDermatitis, AtopicEpidermisHumansImmunity, InnateKeratinocytesSkinAllergensChemokinesCytokinesanti-microbial peptideatopic dermatitischemokinecytokineinnate immunitykeratinocyte

Identifiers

PMID33460469
PMCPMC8119845
OpenAlexW3121136707

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.